Kodiak Sciences, Inc. (KOD)
89.22
+1.10
(+1.25%)
USD |
NASDAQ |
Oct 16, 12:23
Kodiak Sciences SG&A Expense (TTM) : 45.82M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.82M |
| March 31, 2026 | 47.82M |
| December 31, 2025 | 52.02M |
| September 30, 2025 | 54.46M |
| June 30, 2025 | 57.34M |
| March 31, 2025 | 60.06M |
| December 31, 2024 | 60.75M |
| September 30, 2024 | 63.09M |
| June 30, 2024 | 66.65M |
| March 31, 2024 | 69.05M |
| December 31, 2023 | 71.02M |
| September 30, 2023 | 72.35M |
| June 30, 2023 | 71.84M |
| March 31, 2023 | 72.29M |
| December 31, 2022 | 73.79M |
| September 30, 2022 | 73.17M |
| June 30, 2022 | 66.90M |
| March 31, 2022 | 59.08M |
| Date | Value |
|---|---|
| December 31, 2021 | 49.71M |
| September 30, 2021 | 41.74M |
| June 30, 2021 | 37.57M |
| March 31, 2021 | 33.29M |
| December 31, 2020 | 28.62M |
| September 30, 2020 | 22.49M |
| June 30, 2020 | 17.75M |
| March 31, 2020 | 14.50M |
| December 31, 2019 | 11.68M |
| September 30, 2019 | 10.84M |
| June 30, 2019 | 9.89M |
| March 31, 2019 | 6.914M |
| December 31, 2018 | 5.159M |
| September 30, 2018 | 3.484M |
| March 31, 2018 | 1.813M |
| December 31, 2017 | 1.813M |
| September 30, 2017 | 0.831M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.743B |
| AbbVie, Inc. | 14.67B |
| Mirum Pharmaceuticals, Inc. | 313.84M |
| ACADIA Pharmaceuticals, Inc. | 620.29M |
| Alnylam Pharmaceuticals, Inc. | 1.318B |